Titan Pharmaceuticals Stock Shares Owned By Insiders
| TTNP Stock | USD 3.85 0.29 7.00% |
Titan Pharmaceuticals fundamentals help investors to digest information that contributes to Titan Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Titan Stock. The fundamental analysis module provides a way to measure Titan Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Titan Pharmaceuticals stock.
Titan | Shares Owned By Insiders |
Titan Pharmaceuticals Company Shares Owned By Insiders Analysis
Titan Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Titan Pharmaceuticals Shares Owned By Insiders | 45.46 % |
Most of Titan Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Titan Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Titan Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Titan Pharmaceuticals is extremely important. It helps to project a fair market value of Titan Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Titan Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Titan Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Titan Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 45.46% of Titan Pharmaceuticals are shares owned by insiders. This is 199.47% higher than that of the Pharmaceuticals sector and 220.59% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Titan Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Titan Pharmaceuticals' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Titan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Titan Pharmaceuticals by comparing valuation metrics of similar companies.Titan Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Titan Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Titan Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Titan Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Titan Fundamentals
| Return On Equity | -3.69 | ||||
| Return On Asset | -1.73 | ||||
| Current Valuation | (2.42 M) | ||||
| Shares Outstanding | 914.23 K | ||||
| Shares Owned By Insiders | 45.46 % | ||||
| Shares Owned By Institutions | 1.85 % | ||||
| Number Of Shares Shorted | 27.3 K | ||||
| Price To Earning | (3.60) X | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 1,234 X | ||||
| Gross Profit | (4.37 M) | ||||
| EBITDA | (4.56 M) | ||||
| Net Income | (4.71 M) | ||||
| Cash And Equivalents | 6.42 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 483 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.06 X | ||||
| Book Value Per Share | 4.37 X | ||||
| Cash Flow From Operations | (3.88 M) | ||||
| Short Ratio | 1.04 X | ||||
| Earnings Per Share | (6.64) X | ||||
| Target Price | 7.0 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 3.34 M | ||||
| Total Asset | 2.92 M | ||||
| Retained Earnings | (396.54 M) | ||||
| Working Capital | 2.44 M | ||||
| Current Asset | 12.24 M | ||||
| Current Liabilities | 4.85 M | ||||
| Net Asset | 2.92 M |
About Titan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.